Admission Date: [**2134-1-2**]        Discharge Date: [**2134-1-12**]  Date of Birth:  [**2084-11-21**]        Sex:  F  Service:  [**Last Name (un) **]   CHIEF COMPLAINT:  Patient is a 49-year-old patient with hepatitis C virus, diabetes type 2 with end-stage renal disease on hemodialysis who presents for a cadaveric renal transplant.
HISTORY OF PRESENT ILLNESS:  Forty-nine-year-old female admitted with HCV, DM type 2, end-stage renal disease on hemodialysis presenting for a cadaveric renal transplant for DCD donor.
MEDICATIONS ON ADMISSION:  Protonix, folate, multivitamin, Celexa 20 mg daily, Lipitor 10 mg p.o.
daily, travoprost, Epogen, vitamin B, Lopressor 12.5 b.i.d., glargine 7 units and regular sliding scale insulin.
Nephrology was consulted and followed along throughout this hospital course making recommendations with regard to immunosuppression and electrolytes.
Patient received induction immunosuppression of ATG, Solu- Medrol 500 mg x1, and CellCept 1 gram p.o.
She had [**Initials (NamePattern4) **] [**Last Name (NamePattern4) 1661**]- [**Location (un) 1662**] drain draining serosanguineous fluid approximately 200 cc in the PACU.
She was replaced with IV fluid.
She received IV bolus for low urine output without any response.
Borderline arterial and venous waveforms were noted with slight systolic blunting and interruption of diastolic flow.
She was maintained on a dopamine drip postoperatively for BP range of 100-145/50-70.
She was continued on dopamine to keep blood pressure greater than 120 systolic.
She received dialysis on postoperative day 2 for delayed graft function.
She continued on her steroid taper.
She was started on Prograf 4 mg b.i.d.
On postop day 3, she was maintained on maintenance IV fluids.
She was transferred to the medical-surgical unit on [**Hospital Ward Name 121**] 10.
Pain was managed with PCA morphine with good result.
She completed her steroid taper.
On postop day 9, she underwent renal transplant biopsy under ultrasound without complication.
Insulin was adjusted with improved glucoses.
Foley was removed without any problems and she was able to void independently.
Arrangements were set up for outpatient hemodialysis until improved function of delayed renal transplant graft function.
Outpatient hemodialysis was scheduled for [**1-14**].
Visiting nurse services were arranged for drain care, monitoring of vital signs, and Accu-Cheks.
DISCHARGE MEDICATIONS:  Included Bactrim 1 single strength daily, Protonix 40 mg p.o.
daily, nystatin 5 mL p.o.
q.i.d., Colace 1 capsule p.o.
b.i.d., Valcyte 450 mg p.o.
q.o.d., Percocet 1 tablet p.o.
q.4-6h., Reglan 10 mg p.o.
before meals and at bedtime, CellCept elixir 500 mg p.o.
t.i.d., Neutra-Phos 1 packet p.o.
x3 days, Prograf 5 mg p.o.
b.i.d., glargine 6 units nightly, insulin sliding scale regular q.i.d.
p.r.n., Celexa 20 mg p.o.
daily, and Lipitor 10 mg p.o.
DISCHARGE DIAGNOSES:  Diabetes type 2, hypertension, delayed graft function status post cadaveric renal transplant [**2134-1-2**], anemia, depression, hyperlipidemia, lower extremity traumatic skin ulcerations.
